- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 229/30 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
Patent holdings for IPC class C07C 229/30
Total number of patents in this class: 158
10-year publication summary
15
|
14
|
18
|
10
|
8
|
8
|
12
|
8
|
4
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Arbutus Biopharma Corporation | 177 |
9 |
JNC Corporation | 1548 |
9 |
JNC Petrochemical Corporation | 402 |
9 |
Bayer Cropscience AG | 2062 |
6 |
Allnex Belgium S.A. | 153 |
4 |
Idunn Technologies | 6 |
4 |
Suzhou Abogen Biosciences Co., Ltd. | 70 |
4 |
The Procter & Gamble Company | 22018 |
3 |
BASF SE | 20777 |
3 |
The Cleveland Clinic Foundation | 1575 |
3 |
OCERA Therapeutics, Inc. | 40 |
3 |
Sun Chemical Corporation | 840 |
3 |
University of Massachusetts | 2218 |
3 |
Novartis AG | 10904 |
2 |
Centre National de La Recherche Scientifique | 10321 |
2 |
Toshiba Corporation | 12286 |
2 |
President and Fellows of Harvard College | 5949 |
2 |
Alnylam Pharmaceuticals, Inc. | 1146 |
2 |
Microbial Chemistry Research Foundation | 78 |
2 |
NDSU Research Foundation | 245 |
2 |
Other owners | 81 |